Skip Ribbon Commands
Skip to main content
Dr Eberta Tan Jun Hui

Dr Eberta Tan Jun Hui

MBBS (S’pore), M.Med (Internal Medicine), MRCP (UK)

Visiting Consultant

Changi General Hospital

Specialty: Endocrinology

Conditions Treated by this Doctor:
Diabetes Mellitus.

Clinical Appointments

  • Visiting Consultant Endocrinology Changi General HospitalChangi General Hospital


Dr Eberta Tan is a visiting consultant specialist in Endocrinology. Her subspecialty interests are type 1 diabetes mellitus, type 2 diabetes mellitus and gestational diabetes mellitus. She graduated with the degrees of MBBS from the National University of Singapore in 2004, attained membership to The Royal College of Physicians (United Kingdom) in 2008 and qualified as a specialist in endocrinology in 2013. She is currently the assistant director of the Diabetes Mellitus Centre and the co-lead in specialist care of the SingHealth Duke-NUS Diabetes Centre.


  • Advanced Specialty Training, Endocrinology (Singapore, 2013)
  • MRCP (UK, 2008)
  • MBBS (Singapore, 2004)

Professional Appointments and Committee Memberships

  • Visiting Consultant, Raffles Medical Group
  • Clinical Senior Lecturer, NUS Yong Loo Lin School of Medicine
  • Clinical Core Faculty Member, SingHealth Endocrinology Residency Program
  • Physician Faculty Member, SingHealth PGY1 Residency Program
  • Co-Lead, Specialist Care, SingHealth Duke-NUS Diabetes Centre (2017 to present)
  • Chairman, Point-of-Care-Testing Committee, Changi General Hospital (2016 to present)
  • Co-Lead, Hypoglycemia Prevention, Singapore Healthcare Improvement Network (2016 to present)
  • Deputy Director, Diabetes Mellitus Centre, Changi General Hospital (2015 to present)
  • Member, National Steering Committee for Diabetes (2015 to 2017)
  • Reviewer, Diabetes, Obesity and Metabolism (2014 to present)
  • Member, Endocrine and Metabolic Society of Singapore (EMSS) (2009 to present)
  • Member, Singapore Medical Association (2005 to present)


  • Silver Award, Eastern Health Alliance Caring Awards (2017)
  • Eastern Health Alliance FY2014 Innovation Grant Award for “Smart Phone Application for Patients with Diabetes Mellitus” (2014)
  • HMDP Fellowship Award, Eastern Health Alliance, Fellowship in University of Leeds, UK (2013)
  • Role Model for Graduating Class of 2012 (2012)
  • SingHealth Foundation Research Grant for “Effect of levothyroxine on cardiovascular risk factors and endothelial dysfunction in mild subclinical hypothyroidism: a randomised, crossover study (2011)
  • Best Registrar Award, SingHealth Foundation, Singapore (2011)

Research Interests

  • Chronic Disease Management
  • Diabetes


• Managing Diabetes in Pregnancy. Eberta J.H. Tan and Eleanor M. Scott. Endocrinology and Diabetes: Case Studies, Questions and Commenteries. ISBN 978-1-4471-2788-8., Springer-Verlag London 2015. Ramzi Ajjan and Stephen M.

• Circadian rhythms, insulin action, and glucose homeostasis. Tan E, Scott EM. Current Opinion in Clinical Nutrition and Metabolic Care. 2014 Jul; 17(4): 343-8

• Prevalence and Risk Factors of Renal Artery Stenosis in South Asian Patients with Type 2 Diabetes Using Renal Angiography. Tan E, Debajyoti R, Sharma S, Bhatia RD, Barbier S, Khoo J, Ng JM. Indian Journal of Nephrology. 2014 Jan;24(1): 68-69. 

• Pituitary Apoplexy Secondary to Thrombocytopenia Due to Dengue Hemorrhagic Fever: A Case Report and Review of Literature. Tan SK, Seow CJ, Tan E, Chau YP, Dalan R. Endocrine Practice. 2014 Apr;20(4):e58-64

• Comparing the effects of meal replacements with an isocaloric reduced-fat diet on nutrient intake and low urinary tract symptoms in obese men. Khoo J, Ling PS, Chen RY, Ng KK, Tay TL, Tan E, Cho LW, Cheong M. J Hum Nutr Diet. 2014 Jun;27(3):219-26. Epub 2013 Sep 20.

• Comparing the effects of meal replacements with reduced-fat diet on weight, sexual and endothelial function, testosterone and quality of life in obese Asian men. Khoo J, Ling PS, Tan J, Teo A, Ng HL, Chen RY, Tay TL, Tan E, Cheong M. Int J Impot Res. 2014 Mar-Apr;26(2):61-6. Epub 2013 Nov 7.

• Sensitivity of A1C to diagnose diabetes is decreased in high-risk older Southeast Asians. Journal of Diabetes Complications. Khoo J, Tay TL, Foo JP, Tan E, Soh SB, Chen R, Au V, Jen-Min Ng B, Cho LW. 2012 Mar-Apr;26(2):99-101.

• HbA1c may not be a sensitive determinant of diabetic status in the elderly. Tay TL, Foo JP, Tan E, Chen R, Khoo J, Soh SB, Au V, Cho LW. Diabetes Research and Clinical Practice. 2011 May;92(2):e31-3.

Research Trials

  • Genetic Variants in BIM and Diabetes Mellitus. (Site Principal Investigator)
  • Validation of HbA1c Diagnostic Kits. (Principal Investigator)
  • Prospective Diabetes Registry of patients with Type 2 Diabetes Mellitus on SGLT2 inhibitor therapy in Singapore. (Co-Investigator)
  • ELO Water in Diabetes Care for Enhancement of Blood Sugar Control (EDEN Study) – A Double-Blinded Randomized Controlled Trial. (Co-Investigator)
  • Prospective study Assessing blood pressure, Cardiovascular, Endothelial and other outcomes post-surgical and medical treatment in patients with Primary Aldosteronism (PACES_PA). (Co-Investigator)
  • Effect of multidisciplinary intensive targeted care in improving diabetes outcomes: a randomized controlled trial – the Integrated Diabetes Education, Awareness and Lifestyle modification in Singapore (IDEALS) Program. (Co-Investigator)